微创与开放ALPPS的对比:一项系统综述
该研究通过检索多个数据库,比较了微创ALPPS与开放ALPPS的临床结局。分析纳入1088例开放ALPPS和46例微创ALPPS病例,发现微创ALPPS的严重并发症(Clavien-Dindo≥IIIa)发生率较低(p=0.063),中位死亡率显著更低(0.00% vs 8.45%,p=0.007)。但微创ALPPS证据有限,尚需更高质量研究验证其能否替代开放ALPPS。
要点
- 微创ALPPS的中位死亡率为0.00%,显著低于开放ALPPS的8.45%(p=0.007)。
- 微创ALPPS一期术后严重并发症(≥IIIa)发生率较低,但差异无统计学意义(p=0.063)。
- 微创与开放ALPPS在手术时间和出血量上无差异。
核心结论
- 微创ALPPS可能较开放ALPPS降低并发症率和死亡率,但证据有限,需更高质量研究验证其能否替代开放ALPPS。
研究设计与样本
- 检索PubMed、Medline、EMBASE和Cochrane Library数据库(2019年7月10日),纳入19项开放ALPPS研究、3项微创ALPPS研究和1项同时报告两者的研究。
主要发现
- 共分析1088例开放ALPPS和46例微创ALPPS病例。
- 开放ALPPS组基础病理更多样(p=0.028),右扩大半肝切除比例更高(p=0.006)。
- 两组手术时间和出血量无差异。
- 微创ALPPS一期术后严重并发症(≥IIIa)发生率较低(p=0.063)。
- 微创ALPPS中位死亡率显著低于开放ALPPS(0.00% vs 8.45%,p=0.007)。
临床怎么用
- 在具备微创技术条件的中心,可考虑对适合患者行微创ALPPS以降低死亡率和严重并发症风险。
- 需注意现有证据等级不高,决策应个体化并结合团队经验。
局限性
- 微创ALPPS病例数少(46例),证据有限。
- 研究间基线特征存在差异,可能存在选择偏倚。
- 需更高质量证据比较微创与开放ALPPS。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) has gained both interest and controversy, as an alternative to portal vein embolisation (PVE) by inducing future liver remnant hypertrophy in patients at risk of liver failure following major hepatectomy. Open ALPPS induces more extensive hypertrophy in a shorter timespan than PVE; however, it is also associated with higher complication rates and mortality. Minimally invasive surgery (MIS), with its known benefits, has been applied to ALPPS in the hope of reducing the surgical insult and improving functional recovery time while preserving the extensive FLR hypertrophy. METHODS: A search of the PubMed, Medline, EMBASE and Cochrane Library databases was conducted on 10 July 2019. 1231 studies were identified and screened. 19 open ALPPS studies, 3 MIS ALPPS and 1 study reporting on both were included in the analysis. RESULTS: 1088 open and 46 MIS-ALPPS cases were included in the analysis. There were significant differences in the baseline characteristic: open ALPPS patients had a more diverse profile of underlying pathologies (p = 0.028) and comparatively more right extended hepatectomies (p = 0.006) as compared to right hepatectomy and left extended hepatectomy performed. Operative parameters (time and blood loss) did not differ between the two groups. MIS ALPPS had a lower rate of severe Clavien-Dindo complications (≥ IIIa) following stage 1 (p = 0.063) and significantly lower median mortality (0.00% vs 8.45%) (p = 0.007) compared to open ALPPS. CONCLUSION: Although MIS ALPPS would seem to be better than open ALPPS with reduced morbidity and mortality rates, there is still limited evidence on MIS ALPPS. There is a need for a higher quality of evidence on MIS ALPPS vs. open ALPPS to answer whether MIS ALPPS can replace open ALPPS.
引用
- Michal K, Sau M, Tamara GMH, et al. A better route to ALPPS: minimally invasive vs open ALPPS. Surg Endosc. 2020. PMID: 32274625. doi:10.1007/s00464-020-07437-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。